Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia

Read full text Summarise with VIRAT
Authors: Masako Araki, Helga Zoëga, Malcolm Bjørn Gillies, Michael O. Falster, David Peiris, Sallie‐Anne Pearson, Henrik Larsson, Juliana de Oliveira Costa
Cited by: 0
References: 31

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Despite cardiovascular conditions being common in adults with ADHD, data on patterns of cardiovascular medicine use in this population are scarce. METHODS: Using dispensing claims for a 10% random sample of Australians, this population-based study comprised 14,753 adults with ADHD (defined as having ≥2 ADHD medicine dispensings in 2012-2020) who were 1:4 sex- and age-matched with 59,012 adults without ADHD (no ADHD dispensings). We estimated the prevalence of cardiovascular medicine use in 2021 among adults with and without ADHD, overall and by medicine type, sex, and age. Using Poisson regression, we calculated age- and sex-adjusted prevalence ratios (PRs) with 95% confidence intervals (CIs) to assess associations. RESULTS: Overall cardiovascular medicine use was more prevalent among adults with ADHD than those without (16.5% vs. 10.0%, aPR = 1.7, 95% CI [1.6, 1.7]), with the highest difference among those aged 18 to 29 years (aPR = 2.8, 95% CI [2.4, 3.1]). We observed increased differences in use of propranolol (3.2% vs. 0.7%), loop diuretics (0.8% vs. 0.4%), potassium-sparing diuretics (0.9% vs. 0.4%), cardiac therapy (0.8% vs. 0.5%), and antithrombotic agents (2.2% vs. 1.4%). Among females, we noted associations of ADHD with specific diuretic subgroups (loop, aPR = 2.8, 95% CI [2.1, 3.7]; potassium-sparing, aPR = 2.5, 95% CI [1.9, 3.3]). CONCLUSION: We identified an elevated prevalence of cardiovascular medicine use among adults with ADHD, particularly among younger people. We also observed distinct patterns in specific medicine use between sexes, suggesting potential sex-specific effect modification. Our findings underscore the importance of regular monitoring and management of cardiovascular health among people with ADHD across the lifespan.

Fields of Study & Subjects

Attention Deficit Hyperactivity Disorder Blood Pressure and Hypertension Studies Schizophrenia research and treatment

Publication details

Journal / source
Journal of Attention Disorders
Volume
30
Issue
6
Pages
773–783
Publication date
27 March 2026
Language
EN